The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index, and 1 are not checked yet.
Amelioration of osteopenia and hypovitaminosis D by 1alpha -hydroxyvitamin D3 in elderly patients with Parkinson's disease
Open accessAbstract
OBJECTIVES: A high prevalence of hip and other fractures in elderly patients with Parkinson's disease has been linked to reduced bone mass arising from a defect of renal synthesis of 1, 25-dihydroxyvitamin D (1, 25-[OH]2D). Treatment with 1alpha-hydroxyvitamin D3 (1alpha(OH)D3; an active form of vitamin D) was evaluated for maintaining bone mass and reducing the incidence of hip and other nonvertebral fractures in patients with Parkinson's disease. METHODS: In a double blind, randomised trial, 86 elderly patients with Parkinson's disease (mean Hoehn and Yahr stage, 3; mean age 70.6 years) were randomised to receive either 1 microg 1alpha(OH)D3 daily (treatment group, n=43) or a placebo (n=43) for 18 months. Bone mineral densities in the second metacarpals were determined by computed radiographic densitometry. Serum bone turnover indices were measured serially, and incidence of nonvertebral fractures was recorded. RESULTS: Bone mineral densities decreased 1.2% in the treatment group compared with 6.7% in the placebo group during 18 months (p<0.0001). At baseline in both groups, the serum concentration of 1, 25-[OH]2D was reduced. Parathyroid hormone was abnormally increased in 15 patients (17%) and correlated negatively with serum 25-hydroxyvitamin D, indicating compensatory hyperparathyroidism. Eight patients sustained fractures (six at the hip and two at other sites) in the placebo group, and one hip fracture occurred among treated patients (odds ratio 9.8; p=0.0028). CONCLUSION: By increasing serum 1, 25-[OH]2D concentrations, treatment with 1alpha(OH)D3 can reduce the risk of hip and other non-vertebral fractures in osteoporotic elderly patients with Parkinson's disease by slowing the loss of bone mineral densities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Three affected trial reports8 15 16 were cited in the review by Binks and Dobson34 (one citation, 2017) as evidence for the benefit of vitamin D and bisphosphonates in people with Parkinson’s disease.”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In their review of vitamin D and Parkinson’s disease, Peterson et al 33 (16 citations, 2017) base their conclusions almost entirely on data from four affected trial reports.8 9 15 16”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“A guideline from AHRQ57 excluded one trial report8 from its review of interventions to prevent falls in older people. The reason for exclusion was that the report did not focus on the outcome of interest, that is, the rate of falls or number of fallers, despite what appeared to be relevant falls data in the affected trial report.”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease [RETRACTED]
Satō, Y., Kikuyama, M., & Ōizumi, K. (1997) · Neurology · doi:10.1212/wnl.49.5.1273 · Cited by 221
RetractedSato, Y., Maruoka, H., & Oizumi, K. (1997) · Stroke · doi:10.1161/01.str.28.4.736 · Cited by 76
RetractedVitamin D 3 and Calcium to Prevent Hip Fractures in Elderly Women
Chapuy, M. C., ARLOT, M. E., Duboeuf, F., Brun, J., Crouzet, B., Arnaud, S. B., Delmas, P. D., & Meunier, P. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212033272305 · Cited by 2,942
Dawson‐Hughes, B., Harris, S. S., Krall, E. A., & Dallal, G. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371003 · Cited by 2,276
Risk Factors for Falls as a Cause of Hip Fracture in Women
Grisso, J. A., Kelsey, J. L., Strom, B. L., Ghiu, G. Y., Maislin, G., O’Brien, L. A., Hoffman, S., & Kaplan, F. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105093241905 · Cited by 869
Treatment of Postmenopausal Osteoporosis with Calcitriol or Calcium
Tilyard, M., Spears, G. F. S., Thomson, J., & Dovey, S. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202063260601 · Cited by 574
Eriksen, E. F., Charles, P., Melsen, F., Mosekilde, L., Risteli, L., & Risteli, J. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080202 · Cited by 437
Roller, W. C., Glatt, S. L., Vetere-Overfield, B., & HASSANEIN, R. S. (1989) · Clinical Neuropharmacology · doi:10.1097/00002826-198904000-00003 · Cited by 350
Carano, A., Teitelbaum, S. L., Konsek, J. D., Schlesinger, P. H., & Blair, H. C. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114459 · Cited by 314
Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro
Garnero, P., Grimaux, M., Seguin, P., & Delmas, P. D. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090215 · Cited by 241
Flagged first, then by citations
Research works printed but not linked: 4
- Sato Y, Maruoka H, Oizumi K. Amelioration of hemiplegia- associated osteopenia over four years following stroke by 1 -hydroxyvitamin D3 and calcium supplementation. Stroke 1997;28:736-9.
- Inoue T, Orimo H, Koshikawa S, et al. Acronym of improved microdensitometry (computed x ray densitom- etry) [letter]. Journal of Bone and Mineral Metabolism 1994; 12:145.
- Koller WC, Glatt S, Vetere-Overfield B, et al. Falls and Par- kinson's disease. Clin Neuropharmacol 1989;12:98-105.
- Matsumoto C, Kushida K, Sato Y, et al. The second meta- carpal bone density microdensitometry method (in Japa- nese). Seikeigeka 1992;43:1140-6.
Cited by
Sorted by citations
Items 101–129 of 129
Effective Pharmacotherapeutic Interventions for the Prevention of Hip Fractures
Bolognese, M. A. (2002) · The Endocrinologist · doi:10.1097/00019616-200201000-00008 · Cited by 5
Raggi, A., & Ferri, R. (2025) · Psychogeriatrics · doi:10.1111/psyg.70071 · Cited by 4
RETRACTED: Risk factors for hip fracture among elderly patients with Parkinson's disease
Satō, Y., Kaji, M., Tsuru, T., & Ōizumi, K. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)00110-9 · Cited by 3
RetractedNeuroendocrine and metabolic impairments in patients with Parkinson’s disease
Verugina, N. I., Levin, O. S., & Lyashenko, E. A. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202012010267 · Cited by 4
Otaka, Y., Liu, M., Uzawa, M., & Chino, N. (2003) · リハビリテーション医学 : 日本リハビリテーション医学会誌 · doi:10.2490/jjrm1963.40.389 · Cited by 4
Navarro, V. R. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 4
Romero, F. B., Martínez, J. J. A., López, V. L., & Martín, I. G. (2012) · PubMed · doi:10.1590/s0212-16112012000200003 · Cited by 3
Prevention of falls in old people – a review
Karlsson, M. K., Karlsson, C., Cöster, M. C., Magnusson, H. I., & Rosengen, B. E. (2013) · Reviews in Clinical Gerontology · doi:10.1017/s0959259813000051 · Cited by 3
Schacht, E., Kneer, W., & Ma, D. (2008) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 3
Ebeling, P. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00020-3 · Cited by 2
Clinical Aspects of the Use of Vitamin D and Its Metabolites in Osteoporosis
Reid, I. R. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-278-4_14 · Cited by 2
Falls, fear of falling, and falls self-efficacy among adults with multiple sclerosis
Peterson, E. W. (2009) · Figshare · Cited by 2
Reduction of Falls in Elderly. The central role of Alfacalcidol in a multi-dimensional paradigm
(2009) · The Internet Journal of Epidemiology · doi:10.5580/afd · Cited by 2
Belaya, Z. E., SOSUNOVA, N. V., & Rozhinskaya, L. Y. (2008) · Osteoporosis and Bone Diseases · doi:10.14341/osteo2008122-28 · Cited by 1
Baladía, E., Pérez-Surio, A. F., & Martínez-Rodríguez, R. (2016) · Cited by 1
Vitamin D efficacy on fall occurrence in elderly: a literature review
Berrut, G. (2008) · Cited by 1
Vitamin D and its Metabolites and Analogs in the Management of Osteoporosis
Bouillon, R., & Reid, I. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00073-x · Cited by 1
Eficacia del tratamiento farmacológico de la osteoporosis en la prevención de fracturas
García, F. G. (2001) · Revista mexicana de ortopedia y traumatología
Part two: Medical treatment of Parkinson's disease
Nazarko, L. (2005) · Nursing and Residential Care · doi:10.12968/nrec.2005.7.5.18016
Ostéoporose et maladie de Parkinson
Thomas, T. (2013) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2013.01.003
Maladie de Parkinson et ostéoporose
Vaserman, N. (2004) · Revue du Rhumatisme · doi:10.1016/j.rhum.2004.04.016
Nutrition part 1: maintaining a healthy diet
Nazarko, L. (2009) · British Journal of Healthcare Assistants · doi:10.12968/bjha.2009.3.1.38080
Nutritional Support in Chronic Neurodegenerative Diseases
Wirth, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-53171-7_7
Vitamin D and its Metabolites and Analogs in the Management of Osteoporosis
Bouillon, R., & Reid, I. R. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50073-2
神経疾患における転倒・転落の合併症 ―外傷, 骨折について―
勝, 吉. (2006) · 医療 · doi:10.11261/iryo1946.60.46
Behl, T., Madaan, P., Sehgal, A., Makeen, H. A., Albratty, M., Alhazmi, H. A., Meraya, A. M., Anwer, M. K., & Verma, R. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230614145026
Functional food for mitochondrial dysfunction and autophagy in neurodegenerative diseases
Dagar, K., Asati, V., Bharti, S. K., Suryavanshi, A., Shukla, D., Mahapatra, D. K., & Kumar, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18951-7.00003-7
Metadata
- Authors
- Sato, Y., Manabe, S., Kuno, H., & Oizumi, K.
- Affiliations
- Kurume University (JP)
- ORCID
- Manabe, S.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 1999-01-01
- Volume
- 66
- Issue
- 1
- Pages
- 64-68
- ISSN
- 0022-3050 (ISSN-L)
- PMC
- PMC1736147
- OpenAlex
- W2082859231
- Cited by
- 131
- References
- 33
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 3 · 2022: 3 · 2020: 1 · 2019: 5 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 11 · 2012: 4
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2017-08-28)
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- Parkinson's disease, 1α-hydroxyvitamin D3, 1,25-dihydroxyvitamin D, osteopenia, vitamin D deficiency, bone mineral density, hip fracture, non-vertebral fractures, osteoporosis, older adults, parathyroid hormone, bone turnover
- MeSH terms
- Aged, Aged, 80 and over, Bone Diseases, Metabolic, Double-Blind Method, Female, Hip Fractures, Humans, Hydroxycholecalciferols, Male, Parathyroid Hormone, Parkinson Disease, Vitamin D Deficiency, Bone Density
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
